LobbyingQuercis Pharma lobbying by quarter
Quercis Pharma's latest lobbying report covers Q2 2026, at $20K. Its first report covers Q2 2026; the issues it reports most are Manufacturing.
Quercis Pharma
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $20K
- Last 2 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q2 2026
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2026 | $20K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Manufacturing$20K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Food & Drug Administration (FDA)1 reports
- HOUSE OF REPRESENTATIVES1 reports
- SENATE1 reports
- Veterans Affairs, Dept of (VA)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Covenant Government Affairs | $20K | 1 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JOHN ROBERTI | Deputy Director, Joint Strategic Planning | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/09for Q2 | Covenant Government Affairs | $20K |
| 05/06for Q2 | Covenant Government Affairs | Under $5,000 |